News
BioConnection appoints Dr. Gary M. Phillips as the new Chairman of the Supervisory Board
Oss, NL August 26, 2024 BioConnection is pleased to announce the appointment of Dr. Gary M. Phillips as the new Chairman of the Supervisory Board. Dr. Phillips will succeed Rob Prins in this role. Dr. Gary M. Phillips brings over three decades of experience in the...
BioConnection appoints Dr. Gary M. Phillips as the new Chairman of the Supervisory Board
Oss, NL August 26, 2024 BioConnection is pleased to announce the appointment of Dr. Gary M. Phillips as the new Chairman of the Supervisory Board. Dr. Phillips will succeed Rob Prins in this role. Dr. Gary M. Phillips brings over three decades of experience in the...
Lava Therapeutics and BioConnection cooperate to improve cancer treatment
BioConnection announces that Lava Therapeutics (LAVA), a biotechnology company creating and developing next-generation γδ T cell engaging bispecific...
Covid-19 update
Oss, The Netherlands, March 18, 2020. BioConnection has taken precautions related to the global outbreak of the Covid-19 virus. To start with; we...
BioConnection invests in expansion of its current production capacity with a second production line
Oss, The Netherlands, April 8, 2019. BioConnection will invest €12 million in a second, commercial scale, manufacturing line to keep up with the...
BioConnection further strengthens its position in the (bio) pharmaceutical CMO business by adding a Flexible GMP area to its current capabilities.
Oss, The Netherlands, March 13, 2019. BioConnection opens this month, after an intensive engineering and validation program its Flexible GMP area....
Interview Mibiton with BioConnection – February 2018
Interview Mibiton with Alexander Willemse - BioConnection - Download If you want to learn more about how BioConnection can bring value to your...
BioConnection wins FD Gazellen award
BioConnection, Contract Development and Manufacturing Organization, proudly announces that is has won the FD Gazellen status. This...